Type 1 interferons and myositis

被引：59

作者：

Greenberg, Steven A. ^{[1
]}

机构：

[1] Brigham & Womens Hosp, Dept Neurol, Div Neuromuscular Dis, Boston, MA 02115 USA

来源：

ARTHRITIS RESEARCH & THERAPY | 2010年 / 12卷

基金：

美国国家卫生研究院;

关键词：

SYSTEMIC-LUPUS-ERYTHEMATOSUS; INDUCIBLE GENE-EXPRESSION; INFLAMMATORY MYOPATHIES; TUBULORETICULAR INCLUSIONS; PERIPHERAL-BLOOD; ALPHA-INTERFERON; DISEASE-ACTIVITY; DERMATOMYOSITIS PATIENTS; LEUKOCYTE INTERFERON; POSITIVE FEEDBACK;

D O I：

10.1186/ar2885

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Recent studies suggest a mechanistic role for molecules induced by type 1 interferons in the pathogenesis of some forms of myositis. For dermatomyositis, evidence that these molecules injure myofibers seems especially strong. In the group of disorders known as polymyositis, the study of blood samples suggests a potential role. It is unknown what drives the sustained presence of type 1 interferon-inducible molecules in these diseases, as the type 1 interferons themselves have not been specifically detected along with their downstream biomarkers. Therapeutic development for blockade of IFN alpha is in progress aided by the identification of blood genomic biomarkers.

引用

页数：7

共 39 条

[1]

[Anonymous], 2021, A Study to Evaluate Safety, Tolerability and Immune Response in Adults Allergic to Peanut After Receiving Intradermal or Intramuscular Administration of ASP0892 (ARA-LAMP-vax), a Single Multivalent Peanut (Ara h1, h2, h3) Lysosomal Associated Membrane Protein DNA Plasmid Vaccine

[2] Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus [J].

Baechler, EC ;

Batliwalla, FM ;

Karypis, G ;

Gaffney, PM ;

Ortmann, WA ;

Espe, KJ ;

Shark, KB ;

Grande, WJ ;

Hughes, KM ;

Kapur, V ;

Gregersen, PK ;

Behrens, TW .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (05) :2610-2615

[3] An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity [J].

Baechler, Emily C. ;

Bauer, Jason W. ;

Slattery, Catherine A. ;

Ortmann, Ward A. ;

Espe, Karl J. ;

Novitzke, Jill ;

Ytterberg, Steven R. ;

Gregersen, Peter K. ;

Behrens, Timothy W. ;

Reed, Ann M. .

MOLECULAR MEDICINE, 2007, 13 (1-2) :59-68

[4] DERMATOMYOSITIS OF CHILDHOOD - ULTRASTRUCTURAL ALTERATIONS OF MUSCLE AND INTRAMUSCULAR BLOOD-VESSELS [J].

BANKER, BQ .

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 1975, 34 (01) :46-75

[5] A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies [J].

Dastmalchi, M. ;

Grundtman, C. ;

Alexanderson, H. ;

Mavragani, C. P. ;

Einarsdottir, H. ;

Helmers, S. Barbasso ;

Elvin, K. ;

Crow, M. K. ;

Nennesmo, I. ;

Lundberg, I. E. .

ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (12) :1670-1677

[6] MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I ANTIGEN EXPRESSION, IMMUNOLOCALIZATION OF INTERFERON SUBTYPES, AND T-CELL-MEDIATED CYTO-TOXICITY IN MYOPATHIES [J].

EMSLIESMITH, AM ;

ARAHATA, K ;

ENGEL, AG .

HUMAN PATHOLOGY, 1989, 20 (03) :224-231

[7]

FELDMAN D, 1988, LAB INVEST, V58, P584

[8] Cytokines, chemokines, and cell adhesion molecules in inflammatory myopathies [J].

Figarella-Branger, D ;

Civatte, M ;

Bartoli, C ;

Pellissier, JF .

MUSCLE & NERVE, 2003, 28 (06) :659-682

[9] Similar topology of injury to keratinocytes and myofibres in dermatomyositis skin and muscle [J].

Greenberg, S. A. ;

Fiorentino, D. .

BRITISH JOURNAL OF DERMATOLOGY, 2009, 160 (02) :464-465

[10] Interferon-α/β-mediated innate immune mechanisms in dermatomyositis [J].

Greenberg, SA ;

Pinkus, JL ;

Pinkus, GS ;

Burleson, T ;

Sanoudou, D ;

Tawil, R ;

Barohn, RJ ;

Saperstein, DS ;

Briemberg, HR ;

Ericsson, M ;

Park, P ;

Amato, AA .

ANNALS OF NEUROLOGY, 2005, 57 (05) :664-678

← 1 2 3 4 →